Themes: Inflammation

Centenary Institute PhD student, Mark Man Gia Ly has been awarded the Royal Prince Alfred Hospital Medical Officers Association President Prize for Laboratory Research.

The Centenary Institute has given members of the public, school students and stakeholders the opportunity to find out what it’s like to be a scientist – and to better understand what it takes to be at the cutting-edge of medical discovery – with its unique ‘speed dating’ event, held as part of the Spark Festival.

Centenary Institute and University of Sydney PhD student, Lina Daniel, is lead author on a newly published paper that has found that Mycobacterium tuberculosis remodels the architecture of the lymph nodes – limiting the immune system’s ability to overcome tuberculosis (TB) infection.

Clinical Professor Devanshi Seth, Head of the Centenary Institute’s Alcoholic Liver Disease Laboratory is co-author on a newly published study that has identified factors affecting mortality in people drinking extreme amounts of alcohol.

Researchers from the Centenary Institute and the University of Sydney have developed a new nasal vaccination strategy that induces potent lung immunity and protection against the SARS-CoV-2 coronavirus.

The Centenary UTS Centre for Inflammation has hosted the 16th Annual NSW Asthma Meeting (NAMe) held at the Centenary Institute, 17-18 November 2022.

Macrophages are specialised cells from our immune system.

Research led by the Centenary Institute and the University of Sydney – focused on the development of a new nasal COVID-19 vaccine – has received close to $1m in grant funding from the NSW COVID-19 Vaccine Acceleration Research Grants Program.

Research led by the Centenary Institute, the University of Technology Sydney and Ghent University Hospital, Belgium has identified a new therapeutic approach for chronic obstructive pulmonary disease (COPD) – the targeting and inhibition of a protein called RIPK1.

As we age our cells also age. They lose their normal functions and become resistant to cell death.

A new book, ‘The Good Gut Anti-Inflammatory Diet’, has been released by the Centenary Institute, which is full of informative knowledge, recipes and advice to maintain good gut health to control inflammation and to help prevent disease.

The Centenary Institute has celebrated the publication of a new book, 'The Good Gut Anti-Inflammatory Diet’ at a special event, held at the Dymocks Bookstore, Sydney.

A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments for chronic inflammation-related diseases including cardiovascular diseases, according to a recent study from the Centenary Institute.

A new study led by the Centenary Institute and the University of Bonn has revealed new insights into the early stages of chronic obstructive pulmonary disease (COPD), a debilitating respiratory condition characterised by inflammation in the lungs and severe breathing difficulties.

Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, has been interviewed on the Good Reading podcast about his recently published book, ‘The Good Gut Anti-Inflammatory Diet’.

Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients.

The Centenary UTS Centre for Inflammation has hosted the 17th Annual National Airways Meeting (NAMe) held at the Centenary Institute, 26-27 October 2023.

The discovery, led by the Centenary Institute and the University of Technology Sydney, could advance treatments for COPD, a lung condition that makes it difficult to breathe due to narrowed airways and damaged lung tissue. COPD is often caused by smoking or exposure to irritants. Lead study researcher, Dr Gang Liu at the Centenary UTS ...

Research led by the Centenary Institute, the University of Technology Sydney and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary disease (COPD), paving the way for new therapeutic treatments.